» Articles » PMID: 34005845

Bone Densitometry Measurements in Children with Neurofibromatosis Type 1 Using Quantitative Computed Tomography

Overview
Journal Singapore Med J
Specialty General Medicine
Date 2021 May 19
PMID 34005845
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disease characterised by multisystemic involvement, including bone tissue. Deformities and reduced bone mass are the main bone manifestations in NF1. Quantitative computed tomography (QCT) provides true volumetric bone mineral density (BMD) measurement. This study aimed to evaluate bone metabolism parameters and BMD in children with NF1 using QCT.

Methods: The data of 52 paediatric NF1 patients (23 female, 29 male) was evaluated retrospectively. We investigated anthropometric measurements, biochemical parameters like total calcium, phosphate, magnesium, alkaline phosphatase, 25-hydroxyvitamin D (25OHD), parathyroid hormone, calcitonin, urinary calcium/creatinine ratio, and QCT parameters like lumbar trabecular and cortical BMD, trabecular area and cortical thickness. Comparisons of gender and puberty status were performed.

Results: 25% of patients had skeletal deformities and 42.3% had 25OHD inadequacy (<20 ng/mL). The frequency of 25OHD inadequacy was significantly higher in pubertal/postpubertal patients than prepubertal patients (61.9% vs. 29.0%, P = 0.019). Trabecular BMD Z-score was <-2.0 in 11.5% of patients; all with low BMD were at the pubertal/postpubertal stage. There was a significant negative correlation between age and trabecular Z-score (r = -0.41, P = 0.003). Mean cortical BMD was statistically similar between the genders and puberty groups. Puberty status, anthropometric Z-scores, and biochemical and QCT parameters were statistically similar between the genders (P > 0.05).

Conclusion: Paediatric NF1 patients may present with low BMD and 25OHD inadequacy, especially at puberty. QCT may be a useful tool to evaluate trabecular and cortical bone separately in NF1 patients.

Citing Articles

Opportunistic screening for bone mineral density deficits in pediatric patients from abdominal computed tomography scans obtained for other indications: a cross-sectional study.

Liu C, Yang D, Chen X, Liao Y, Ning G, Qu H Pediatr Radiol. 2025; .

PMID: 39964436 DOI: 10.1007/s00247-025-06195-5.


Low bone mineral density and its influencing factors in spinal muscular atrophy without disease-modifying treatment: a single-centre cross-sectional study.

Liu C, Yang D, Luo L, Ma X, Chen X, Liao Y BMC Pediatr. 2024; 24(1):651.

PMID: 39394064 PMC: 11468260. DOI: 10.1186/s12887-024-05120-3.

References
1.
George-Abraham J, Martin L, Kalkwarf H, Rieley M, Stevenson D, Viskochil D . Fractures in children with neurofibromatosis type 1 from two NF clinics. Am J Med Genet A. 2013; 161A(5):921-6. DOI: 10.1002/ajmg.a.35541. View

2.
Wu X, Estwick S, Chen S, Yu M, Ming W, Nebesio T . Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells. Hum Mol Genet. 2006; 15(19):2837-45. DOI: 10.1093/hmg/ddl208. View

3.
Seitz S, Schnabel C, Busse B, Schmidt H, Beil F, Friedrich R . High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1. Osteoporos Int. 2009; 21(1):119-27. DOI: 10.1007/s00198-009-0933-y. View

4.
Armstrong L, Jett K, Birch P, Kendler D, McKay H, Tsang E . The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case-control study. Am J Med Genet A. 2013; 161A(7):1654-61. DOI: 10.1002/ajmg.a.36001. View

5.
Schnabel C, Dahm S, Streichert T, Thierfelder W, Kluwe L, Mautner V . Differences of 25-hydroxyvitamin D3 concentrations in children and adults with neurofibromatosis type 1. Clin Biochem. 2014; 47(7-8):560-3. DOI: 10.1016/j.clinbiochem.2014.02.020. View